Definium Therapeutics, Inc. — All Filings
437 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B5
424B7
6-K
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFC14A
DFAN14A
EFFECT
F-10
F-10/A
F-X
PRE 14A
PREC14A
PRER14A
PRRN14A
S-3
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-126830 | Mar 26, 2026 | Mar 25, 2026 |
| 4 | 4 | 0001193125-26-126827 | Mar 26, 2026 | Mar 25, 2026 |
| 4 | 4 | 0001193125-26-126825 | Mar 26, 2026 | Mar 25, 2026 |
| 144 | — | 0001950047-26-003007 | Mar 25, 2026 | — |
| 144 | — | 0001950047-26-003006 | Mar 25, 2026 | — |
| 144 | — | 0001950047-26-003005 | Mar 25, 2026 | — |
| 10-K | 10-K | 0001193125-26-076742 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-076612 | Feb 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001831942-26-000006 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000938206-26-000012 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-001011 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-26-000710 | Feb 13, 2026 | — |
| 4 | 4 | 0001193125-26-039598 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039585 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039579 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039576 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039571 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-029915 | Jan 29, 2026 | — |
| 3 | 3 | 0001193125-26-029913 | Jan 29, 2026 | — |
| 8-K | 8-K | 0001193125-26-028186 | Jan 29, 2026 | Jan 28, 2026 |
| 8-K | 8-K | 0001193125-26-009854 | Jan 12, 2026 | Jan 9, 2026 |
| 4 | 4 | 0001193125-25-335484 | Dec 29, 2025 | Dec 26, 2025 |
| 4 | 4 | 0001193125-25-335483 | Dec 29, 2025 | Dec 26, 2025 |
| 4 | 4 | 0001193125-25-335481 | Dec 29, 2025 | Dec 26, 2025 |
| 144 | — | 0001104659-25-124863 | Dec 29, 2025 | — |
| 144 | — | 0001104659-25-124861 | Dec 29, 2025 | — |
| 144 | — | 0001104659-25-124857 | Dec 29, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-004830 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-269596 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-269548 | Nov 6, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-104696 | Oct 31, 2025 | Oct 29, 2025 |
| 424B5 | 424B5 | 0001104659-25-104545 | Oct 31, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-103726 | Oct 29, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-103716 | Oct 29, 2025 | — |
| 4 | 4 | 0001193125-25-220848 | Sep 26, 2025 | Sep 25, 2025 |
| 4 | 4 | 0001193125-25-220847 | Sep 26, 2025 | Sep 25, 2025 |
| 4 | 4 | 0001193125-25-220843 | Sep 26, 2025 | Sep 25, 2025 |
| 144 | — | 0001950047-25-007518 | Sep 25, 2025 | — |
| 144 | — | 0001950047-25-007517 | Sep 25, 2025 | — |
| 144 | — | 0001950047-25-007516 | Sep 25, 2025 | — |
| 8-K | 8-K | 0000950170-25-112973 | Sep 4, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-100925 | Jul 31, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-100902 | Jul 31, 2025 | — |
| 4 | 4 | 0000950170-25-090431 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090429 | Jun 26, 2025 | Jun 25, 2025 |
| 4 | 4 | 0000950170-25-090428 | Jun 26, 2025 | Jun 25, 2025 |
| 144 | — | 0001950047-25-004604 | Jun 25, 2025 | — |
| 144 | — | 0001950047-25-004602 | Jun 25, 2025 | — |
| 144 | — | 0001950047-25-004601 | Jun 25, 2025 | — |
| S-8 | FORM S-8 | 0001104659-25-061150 | Jun 20, 2025 | — |